Final answer:
During the EMPA-REG Outcomes trial, patients were allowed to remain on standard of care medications.
Step-by-step explanation:
During the EMPA-REG Outcomes trial, patients were allowed to remain on standard of care medications, such as CV (cardiovascular) and glycemic lowering medications.